Two drugs known to improve survival for patients with metastatic renal cell carcinoma do not reduce the risk of cancer recurrence when administered after surgery, according to a recent clinical trial.
Menu
Browsing: Clinical Breakthroughs
Two simple behavioral interventions decreased the rate of unnecessary antibiotic prescriptions for acute respiratory tract infections, according to a recent paper co-authored by Northwestern Medicine investigator Stephen Persell, MD, MPH.
A recent clinical trial co-led by Mary McDermott, MD, ’92 GME, and colleagues found that increasing physical activity in sedentary older men and women did not prevent serious fall injuries.
A recent clinical trial conducted by Northwestern Medicine investigator Seema Singhal, MD, showed that the drug daratumumab is a safe and effective treatment for patients with advanced multiple myeloma.
A new Northwestern Medicine study showed that deficient vitamin D blood levels in men can predict aggressive prostate cancer.
A phase III clinical trial tested the effectiveness of a combination of two drugs and found they may be an effective and safe treatment for patients with metastatic breast cancer.
A team left by Northwestern Medicine biomedical engineer Patrick Kiser, PhD, designed an intravaginal ring equipped with a novel drug release mechanism that enables the delivery of a diverse array of drugs for extended durations.
Out-of-towners using marijuana in Colorado – where the drug is legal – are ending up in emergency rooms at an increasing rate, according to a new Northwestern Medicine study.
A new study suggests giving the steroid betamethasone to women at risk for late preterm delivery significantly reduces the rate of neonatal complications.
Patients with cancer who watched personalized educational videos before their first visit with an oncologist were better equipped to consider participating in clinical trials, reports a paper co-authored by Northwestern Medicine investigator Al B. Benson, III, MD.